D
Dominique Legros
Researcher at World Health Organization
Publications - 71
Citations - 3433
Dominique Legros is an academic researcher from World Health Organization. The author has contributed to research in topics: Population & Cholera vaccine. The author has an hindex of 34, co-authored 71 publications receiving 3097 citations. Previous affiliations of Dominique Legros include Médecins Sans Frontières.
Papers
More filters
Journal ArticleDOI
Treatment of human African trypanosomiasis; present situation and needs for research and development
Dominique Legros,Gaëlle Ollivier,Marc Gastellu-Etchegorry,Christophe Paquet,Christian Burri,Jean Jannin,Philippe Büscher +6 more
TL;DR: There may soon be no effective drugs available to treat trypanosomiasis patients, especially second-stage cases, because of resistance to and limited number of current treatments, and ambitious research programmes for new compounds must be supported to ensure the sustainable development of new drugs.
Journal ArticleDOI
Conflict and emerging infectious diseases.
TL;DR: Public health interventions and surveillance and response systems can contribute to disease control and improve the quality of life for patients and policymakers.
Journal ArticleDOI
Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda
TL;DR: The Paracheck Pf dipstick and device was considered as the most appropriate for the use in the field, being (97%), moderately specific, reliable, easy to use and cheap (about US$ 0.5/test).
Journal ArticleDOI
Use of Vibrio cholerae Vaccine in an Outbreak in Guinea
Francisco J. Luquero,Lise Grout,Keita Sakoba,Bala Traore,Melat Heile,Alpha Amadou Diallo,Christian Itama,Marie-Laure Quilici,Martin A. Mengel,José María Eiros,Micaela Serafini,Dominique Legros,Rebecca F. Grais,Abstr Act +13 more
TL;DR: Evidence supporting the addition of vaccination as part of the response to an outbreak in Guinea supports the ongoing efforts to establish a cholera vaccine stockpile for emergency use, which would enhance outbreak prevention and control strategies.
Journal ArticleDOI
Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.
TL;DR: The treatment failure rate after melarsoprol observed in Arua is greatly above the expected figures of 3-9%.